SubjectWell expands sales leadership team to drive patient recruitment innovation

Share:

AUSTIN, Texas (April 8, 2025) – SubjectWell, a company transforming patient recruitment by addressing the greatest challenges in clinical development, is proud to announce the addition of three accomplished Vice Presidents of Sales to its growing team: Nathaniel Celentano, Dana Ennis, and Ken Wallace. This expansion strengthens SubjectWell’s ability to disrupt the traditional patient recruitment landscape and accelerate clinical trial enrollment.

 

With extensive experience in clinical development and patient engagement, these leaders bring strategic vision and a deep commitment to patient-centric solutions. Their expertise will play a pivotal role in helping trial sponsors navigate recruitment challenges and connect more patients with life-changing treatments.

 

“With protocol complexity, evolving patient needs, regulatory uncertainty, and increasing costs, sponsors need a new approach to patient recruitment”, said Fred Martin, CEO of SubjectWell. “Our new leaders bring a depth of clinical experience fueling their ability to identify and champion the right technologies, services, and patient support that shifts the current paradigm and accelerates clinical success.”

 

As SubjectWell continues to grow, the company remains committed to improving access, awareness, and diversity in clinical trials. Leveraging its technology-driven approach, a Patient Network of more than 13 million patients, the industry’s largest global reach, and comprehensive patient support services, SubjectWell enhances clinical trial success, reduces site burden, and improves the overall patient experience beyond recruitment.

 

###

About SubjectWell

SubjectWell drives sponsors, CROs, sites, and site networks to disrupt patient recruitment. With the most comprehensive and patient-centric technology platform driven by a growing Patient Network of 13 million+ patients, clinically trained, multilingual patient and site companions across 8,800+ sites and global recruiting capabilities across 600+ indications. Paired with the most extensive digital media network and services proven to reduce site burden, SubjectWell offers solutions to the greatest challenges in patient recruitment and clinical development. To learn more, visit www.subjectwell.com.

Related articles

Accelerate your recruitment today

SubjectWell is here to help you reach, recruit, and retain the patients you need for a successful clinical trial. Schedule a demo to see how SubjectWell+ can support your clinical study’s patient recruitment goals.